FDA Approval of PiaSky for Pediatric Patients with PNH @AAMDSIF

FDA Approval of PiaSky for Pediatric Patients with PNH @AAMDSIF

Uploaded July 2024 | Updated September 2026, 19 hours ago

Dr. Satheesh Chonat describes the use of this medication for pediatric patients with PNH, or paroxysmal nocturnal hemoglobinuria.
For more podcast episodes like this, please visit aamds.org/podcast (aamds.org/education/podcast-episodes).

FDA Approval of PiaSky for Pediatric Patients with PNH

Managing Treatment Symptoms with Diet with Joanna Myers Casale, RD, CSO

Treatments for MDS and Secondary AML - Part 2, High-Risk

Learn about newly approved oral medication for patients with PNH

Understanding Low Risk MDS 2021 Winter Patient Family Conference

High-Risk MDS and Secondary AML with Hetty Carraway, MD, MBA and Amer Zeidan, MD

What is the IPSS-M for MDS? With Dr. Gail Roboz

Mucocutaneous GVHD

MDS and Non-Transplant Therapies from the Patient and Family Conference in Salt Lake City, UT, 2023

Cytopenia Management of Low Risk MDS, or Myelodysplastic Syndromes

Athletic Service Member Conquers Aplastic Anemia and MDS with Transplant

AAMDSIF 40th Anniversary Summit: The Future of Clinical Trials Panel Discussion

FDA Approval of PiaSky for Pediatric Patients with PNH